Literature DB >> 15107848

SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans Polycomb group protein SOP-2.

Hong Zhang1, Gromoslaw A Smolen, Rachel Palmer, Andrea Christoforou, Sander van den Heuvel, Daniel A Haber.   

Abstract

Post-translational modification of proteins by the ubiquitin-like molecule SUMO (sumoylation) regulates their subcellular localization and affects their functional properties in vitro, but the physiological function of sumoylation in multicellular organisms is largely unknown. Here, we show that the C. elegans Polycomb group (PcG) protein SOP-2 interacts with the SUMO-conjugating enzyme UBC-9 through its evolutionarily conserved SAM domain. Sumoylation of SOP-2 is required for its localization to nuclear bodies in vivo and for its physiological repression of Hox genes. Global disruption of sumoylation phenocopies a sop-2 mutation by causing ectopic Hox gene expression and homeotic transformations. Chimeric constructs in which the SOP-2 SAM domain is replaced with that derived from fruit fly or mammalian PcG proteins, but not those in which the SOP-2 SAM domain is replaced with the SAM domains of non-PcG proteins, confer appropriate in vivo nuclear localization and Hox gene repression. These observations indicate that sumoylation of PcG proteins, modulated by their evolutionarily conserved SAM domain, is essential to their physiological repression of Hox genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107848     DOI: 10.1038/ng1336

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  41 in total

1.  Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.

Authors:  Matthew Smith; Daniel R Mallin; Jeffrey A Simon; Albert J Courey
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 2.  Orphan nuclear bodies.

Authors:  Maria Carmo-Fonseca; Maria T Berciano; Miguel Lafarga
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-07       Impact factor: 10.005

3.  Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.

Authors:  Inmaculada Hernández-Muñoz; Panthea Taghavi; Coenraad Kuijl; Jacques Neefjes; Maarten van Lohuizen
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Chromatin regulation and sumoylation in the inhibition of Ras-induced vulval development in Caenorhabditis elegans.

Authors:  Gino Poulin; Yan Dong; Andrew G Fraser; Neil A Hopper; Julie Ahringer
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

5.  MafG sumoylation is required for active transcriptional repression.

Authors:  Hozumi Motohashi; Fumiki Katsuoka; Chika Miyoshi; Yasuhiro Uchimura; Hisato Saitoh; Claire Francastel; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  SUMO conjugation attenuates the activity of the gypsy chromatin insulator.

Authors:  Maya Capelson; Victor G Corces
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

7.  SUMOylation is essential for sex-specific assembly and function of the Caenorhabditis elegans dosage compensation complex on X chromosomes.

Authors:  Rebecca R Pferdehirt; Barbara J Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 8.  A new world of Polycombs: unexpected partnerships and emerging functions.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2013-11-12       Impact factor: 53.242

9.  Transcriptional silencing of a transgene by RNAi in the soma of C. elegans.

Authors:  Alla Grishok; Jina L Sinskey; Phillip A Sharp
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

Review 10.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.